Cryopyrin-associated periodic syndrome
Other Names for this Disease
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
(Novartis Pharmaceuticals Corporation)
The FDA has approved this product to be used in this manner.
|Treatment of cryopyrin-associated periodic syndromes (CAPS), in adults and children 4 years of age and older. Also approved for the treatment of active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 through 16 years.|
|More Information about this product||Drug Information Portal|